Even partial protection of one dose could be enough to slow the spread of the virus, the UW Medicine researchers argue in a paper.

MEDIA CONTACT: Susan Gregg - 206.616.6730, sghanson@uw.edu

Giving one dose of the COVID-19 vaccines currently approved in the United States could curtail the spread of the SARS-CoV-19 in the community more quickly than the recommended two doses, say two vaccine experts at the University of Washington School of Medicine.

The U.S. Food and Drug Administration (FDA) has granted emergency use for two new coronavirus vaccines, one developed by the drug company Pfizer and the biotech company BioNTech and the other by the biotech company ModernaTX. Both are mRNA vaccines and have similar structure.

Both vaccines contain modified mRNA that provides the instructions for the synthesis of the SARS-CoV-2 spike glycoprotein antigen. Its mRNA is enveloped in lipid nanoparticles (LNPs) to prevent degradation and enhance uptake into cells.

A global report and U.S. brief published in The Lancet show that further climate protections could save millions of lives.

Each year, The Lancet Countdown tracks more than 40 indicators on links between health and climate change. This year presents the most worrisom outlook to date as key trends worsen. The latest report finds that, with climate action, the lives of millions could be improved and saved.

First-generation students are typically defined as first in their family to obtain a bachelor’s degree. Being a first generation student, who doesn't have a family history of higher education, takes courage and determination and is an identity to be proud of.